Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

UNITED THERAPEUTICS (UTHR) Income from Continuing Operations: 2009-2024

Historic Income from Continuing Operations for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $1.2 billion.

  • UNITED THERAPEUTICS's Income from Continuing Operations rose 9.58% to $338.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 14.47%. This contributed to the annual value of $1.2 billion for FY2024, which is 21.35% up from last year.
  • As of FY2024, UNITED THERAPEUTICS's Income from Continuing Operations stood at $1.2 billion, which was up 21.35% from $984.8 million recorded in FY2023.
  • Over the past 5 years, UNITED THERAPEUTICS's Income from Continuing Operations peaked at $1.2 billion during FY2024, and registered a low of $475.8 million during FY2021.
  • For the 3-year period, UNITED THERAPEUTICS's Income from Continuing Operations averaged around $969.1 million, with its median value being $984.8 million (2023).
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first surged by 592.63% in 2020, then declined by 7.58% in 2021.
  • Yearly analysis of 5 years shows UNITED THERAPEUTICS's Income from Continuing Operations stood at $514.8 million in 2020, then fell by 7.58% to $475.8 million in 2021, then soared by 52.86% to $727.3 million in 2022, then surged by 35.40% to $984.8 million in 2023, then climbed by 21.35% to $1.2 billion in 2024.